TIRAP is implicated in the TLR2- and TLR4-mediated MyD88-dependent signaling pathways; thus, TIRAP gene variants can modulate the signaling pathways and further the secretion of cytokines and inflammatory mediators, which can influence the course and progression of SLE. Here, MYD88 is linked to systemic lupus erythematosus.